Avida Global has appointed Peter Donovan as global commercial director.
Thousands of MS patients are being denied access to Sativex, despite it receiving NICE approval two years ago.
Cannabis may provide some much needed relief to patients who have suffered years of disrupted sleep as a result of RLS
The move has been described as a 'historic moment' for cannabis businesses across the world
With around 35,000 GP’s across the UK, are they the key to unlocking wider access to medical cannabis?
Curaleaf is bringing its second range of medical cannabis flower products to the UK market
The study will measure improvements in wellbeing, quality of life, pain, sleep and anxiety.
It will help shape the next phase of the regulated cannabis sector on the British Isles
The UK’s largest CBD and hemp expo will take place this August
Research in the Netherlands will study the effectiveness of medical cannabis in children with epilepsy